Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR17 | Q13304 | 3/20 | 0.37 |
| ▸ | FBP1 | P09467 | 1/20 | 0.37 |
| ▸ | PTGES | O14684 | 7/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 7/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7551410 | 0.95 | GPR17 (0.34) | GPR17FBP1PTGES | |
| SCHEMBL7555556 | 0.92 | GPR17 (0.33) | GPR17FBP1PTGS2 | |
| Hydrochloric Acid SCHEMBL7554197 | 0.92 | GPR17 (0.32) | GPR17FBP1 | |
| SCHEMBL7550574 | 0.87 | KDM4E (0.32) | GPR17 | |
| SCHEMBL7549055 | 0.85 | PTGES (0.33) | GPR17PTGESPTGS2 | |
| Hydrochloric Acid SCHEMBL7547508 | 0.85 | PTGES (0.33) | GPR17PTGESPTGS2 | |
| SCHEMBL7553553 | 0.78 | MEN1 (0.30) | — | |
| SCHEMBL7548653 | 0.76 | PTGES (0.38) | GPR17FBP1PTGESPTGS2 | |
| SCHEMBL7548276 | 0.74 | GPR17 (0.38) | GPR17FBP1 | |
| SCHEMBL7550465 | 0.73 | MAPK14 (0.31) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0657427-B1 | Tricyclic indole-2-carboxylic acid derivatives being selective antagonists of the NMDA receptor | SUMITOMO PHARMA (JP) | 2002-06-19 | — | — | EP | disclosed |
| US-5496843-A | Tricyclic indole-2-carboxylic acid derivatives | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1996-03-05 | — | — | US | disclosed |
| EP-0657427-A1 | Tricyclic indole-2-carboxylic acid derivatives being selective antagonists of the NMDA receptor | SUMITOMO PHARMACEUTICALS COMPANY, LIMITED (JP) | 1995-06-14 | — | — | EP | disclosed |